Venmax Drugs board meeting scheduled for May 14, 2026 to approve audited Q4 and FY26 financial results.
Trading window closed from April 1, 2026 and will remain closed until May 16, 2026 post-results approval.
Disclosure made under SEBI Listing Regulations Regulation 29 for mandatory board meeting intimation.